← Open Payments lookup

JENNIFER MORRIS: Open Payments

NPI 1871225540 · GARDENDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,133 in 110 payments from 17 companies in 2025. Trend: 2023 $1,318 · 2024 $1,634 · 2025 $2,133

Food & beverage: $2,133
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.13$297
AstraZeneca Pharmaceuticals LP13$230
GlaxoSmithKline, LLC.11$223
Bayer Healthcare Pharmaceuticals Inc.10$167
Novo Nordisk Inc7$166
Boehringer Ingelheim Pharmaceuticals, Inc.9$144
Amgen Inc.7$140
Dexcom, Inc.7$129
Corcept Therapeutics5$118
Paratek Pharmaceuticals, Inc.7$105

Products named: GEMTESA, TRELEGY ELLIPTA, Kerendia, JARDIANCE, FARXIGA, REPATHA, Dexcom G6 Transmitter, Ozempic.

Industry payments across AL — which companies pay providers there.